Aspirin Prevents Colon Cancer Risk

Low-dose aspirin are consumed every day in the long term effective way to reduce the risk of colorectal cancer up to one quarter. The risk of dying from this disease is also reduced by a third.

Earlier low-dose aspirin is also recommended for patients who have a high risk of heart attack and stroke. In the prevention of colon cancer or colon cancer, aspirin in high doses are effective but have side effects bleeding.

Therefore, experts tried to examine whether if the dose is lowered, the effect remains the same protection. In this study the researchers followed up four research conducted in England and Sweden between the years 1980-1990 on the effects of aspirin in cardiovascular patients.

In general, the research for six years, participants were asked to take aspirin in doses of 1200 mg or placebo pills. More than 14,000 patients who attended medical history for 18 years, 391 colorectal cancers.

Those who took aspirin, the risk of cancer was reduced by 24 percent and mortality risk can be reduced to 35 percent. The results of this research is consistent in the four studies. Unfortunately there are no data on side effects in long-term aspirin use because since the beginning of this study was designed to examine cardiovascular disease.

"The results of this study indicate the use of low-dose aspirin in the long term in combination with screening can reduce the incidence of cancer throughout the colon and rectum," says Peter Rothwell, of Oxford University.

Colorectal cancer is one of the most common types of cancer occur in men and women. The risk of this cancer seems more frequent in those with diets high in fat and low in vegetables and fresh fruit. Colorectal cancer risk was also higher in smokers, drinkers and those with less exercise.